Perkins Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$4.1M Sell
62,906
-89
-0.1% -$5.59K 0.05% 174
2016
Q4
$3.94M Buy
62,995
+1,700
+3% +$104K 0.05% 178
2016
Q3
$3.87M Sell
61,295
-937
-2% -$60.7K 0.05% 172
2016
Q2
$3.85M Sell
62,232
-10,510
-14% -$640K 0.06% 180
2016
Q1
$4.16M Sell
72,742
-203
-0.3% -$11.3K 0.06% 184
2015
Q4
$4.32M Sell
72,945
-89,266
-55% -$5.14M 0.06% 173
2015
Q3
$5.11M Sell
162,211
-34,800
-18% -$2.27M 0.07% 167
2015
Q2
$13.2M Sell
197,011
-9,254
-4% -$604K 0.15% 151
2015
Q1
$12.1M Buy
206,265
+34,438
+20% +$2.08M 0.12% 164
2014
Q4
$11.2M Sell
171,827
-44,451
-21% -$2.8M 0.11% 182
2014
Q3
$12.5M Buy
216,278
+75,177
+53% +$4.17M 0.11% 165
2014
Q2
$7.96M Buy
141,101
+19,996
+17% +$1.05M 0.06% 183
2014
Q1
$6.22M Buy
121,105
+1,305
+1% +$66K 0.05% 193
2013
Q4
$6.33M Sell
119,800
-5,790
-5% -$285K 0.04% 199
2013
Q3
$5.62M Buy
125,590
+1,510
+1% +$66.9K 0.04% 204
2013
Q2
$5.13M Buy
+124,080
New +$5.43M 0.03% 219

Other funds holding ABBV

Perkins Investment Management's ABBV Position: Q1 2017 in Review

Perkins Investment Management reduced its AbbVie (ABBV) stake by 0.14% in Q1 2017, selling an estimated $5.59K and leaving 62,906 shares worth $4.1M. The position accounts for 0.05% of the portfolio, ranked #174.

Perkins Investment Management first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $13.2M in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Perkins Investment Management held 62,906 shares of AbbVie worth $4.1M as of Q1 2017.
  • Perkins Investment Management sold 89 AbbVie shares in Q1 2017, an estimated $5.59K.
  • AbbVie made up 0.05% of Perkins Investment Management's portfolio in Q1 2017, its #174 holding.
  • Perkins Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
  • Perkins Investment Management's AbbVie position peaked at $13.2M in Q2 2015.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.